Immunocore Holdings plc (IMCR) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
14/25
Growth 2
Margin 5
Expansion 3
Platform 2
Financial 2
latest quarter score
Earnings Reports
- 14
- 16
- 17